As of Monday, more Americans have received at least one dose of a COVID-19 vaccine that has not tested positive for the disease, according to the Bloomberg vaccine tracker.
Bloomberg data on vaccinations show that 26.5 million Americans have received one or more doses of the vaccine, surpassing the total of nearly 26.3 million cases of coronavirus that Johns Hopkins University has recorded.
Vaccine tracker Bloomberg has determined that the United States vaccinates people at a faster rate than any other country, with about 1.34 million shots a day.
Since the Pfizer-BioNTech vaccine became the first available in the United States last month, followed by the Modern vaccine, nearly 7.8% of Americans have received one or more doses of vaccine and 1, 8%, or 5.82 million, have received the necessary doses. .
According to Bloomberg, three other nations achieved the goal of having more vaccines than confirmed cases before the United States: Israel, the United Kingdom, and the United Arab Emirates, although the actual number of people are not yet identified.
In the United States, deaths and hospitalizations reached unprecedented peaks in January and have only just begun to decline.
Vaccines bring the country closer to herd immunity, which will prevent the spread of the virus. Health experts, including the leading US infectious disease expert Anthony Fauci
Anthony Fauci Fauci says Johnson & Johnson vaccine is useful in fighting COVID-19 despite its lower efficacy Proper use of PCR is needed for a pandemic-focused response. Fauci expects to see vaccinations for children in late spring and early summer, estimate that between 70 and 85 percent of the American population needs to be vaccinated to get to this point.
Countries around the world are currently treating COVID-19 variants, which are found for the first time in the UK and South Africa, which are believed to be more contagious than the original strain. Early studies of the Pfizer-BioNTech vaccine have suggested that it is still effective against mutations in these strains.